- Home
- RYAM vs ORIC Comparison
RYAM vs ORIC Comparison
Compare RYAM & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYAM
- ORIC
- Stock Information
- Founded
- RYAM 1926
- ORIC 2014
- Country
- RYAM United States
- ORIC United States
- Employees
- RYAM N/A
- ORIC N/A
- Industry
- RYAM Paper
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- RYAM Basic Materials
- ORIC Health Care
- Exchange
- RYAM Nasdaq
- ORIC Nasdaq
- Market Cap
- RYAM 577.2M
- ORIC 633.7M
- IPO Year
- RYAM N/A
- ORIC 2020
- Fundamental
- Price
- RYAM $8.91
- ORIC $9.12
- Analyst Decision
- RYAM Buy
- ORIC Strong Buy
- Analyst Count
- RYAM 1
- ORIC 9
- Target Price
- RYAM $12.00
- ORIC $18.75
- AVG Volume (30 Days)
- RYAM 654.9K
- ORIC 482.7K
- Earning Date
- RYAM 11-05-2024
- ORIC 11-12-2024
- Dividend Yield
- RYAM N/A
- ORIC N/A
- EPS Growth
- RYAM N/A
- ORIC N/A
- EPS
- RYAM N/A
- ORIC N/A
- Revenue
- RYAM $1,630,290,000.00
- ORIC N/A
- Revenue This Year
- RYAM $0.53
- ORIC N/A
- Revenue Next Year
- RYAM $2.60
- ORIC N/A
- P/E Ratio
- RYAM N/A
- ORIC N/A
- Revenue Growth
- RYAM N/A
- ORIC N/A
- 52 Week Low
- RYAM $3.02
- ORIC $6.33
- 52 Week High
- RYAM $10.28
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- RYAM 52.06
- ORIC 46.99
- Support Level
- RYAM $7.91
- ORIC $8.11
- Resistance Level
- RYAM $10.28
- ORIC $8.90
- Average True Range (ATR)
- RYAM 0.40
- ORIC 0.74
- MACD
- RYAM -0.06
- ORIC -0.09
- Stochastic Oscillator
- RYAM 39.11
- ORIC 33.78
About RYAM Rayonier Advanced Materials Inc.
Rayonier Advanced Materials Inc manufactures high-purity cellulose derived from wood. Also known as cellulose specialties, the company's products are used in a variety of applications, including cigarette filters, liquid crystal displays, paints, pharmaceuticals, and food. The company operates in the reportable segments of High Purity Cellulose, Paperboard, High-Yield Pulp, and Corporate and Other. The key revenue is derived from the High Purity Cellulose segment. Geographically, it derives a majority of revenue from the United States.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.